ID   ASPH_HUMAN              Reviewed;         758 AA.
AC   Q12797; A6NDF4; A6NHI2; B4DIC9; B4E2K4; B7ZM95; E5RGP5; F5H667;
AC   Q6NXR7; Q8TB28; Q9H291; Q9H2C4; Q9NRI0; Q9NRI1; Q9Y4J0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 3.
DT   10-MAY-2017, entry version 171.
DE   RecName: Full=Aspartyl/asparaginyl beta-hydroxylase;
DE            EC=1.14.11.16 {ECO:0000269|PubMed:11773073};
DE   AltName: Full=Aspartate beta-hydroxylase;
DE            Short=ASP beta-hydroxylase;
DE   AltName: Full=Peptide-aspartate beta-dioxygenase;
GN   Name=ASPH; Synonyms=BAH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7821814; DOI=10.1016/0378-1119(94)90460-X;
RA   Korioth F., Gieffers C., Frey J.;
RT   "Cloning and characterization of the human gene encoding aspartyl
RT   beta-hydroxylase.";
RL   Gene 150:395-399(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8823296; DOI=10.1172/JCI118918;
RA   Lavaissiere L., Jia S., Nishiyama M., de la Monte S., Stern A.M.,
RA   Wands J.R., Friedman P.A.;
RT   "Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in
RT   hepatocellular carcinoma and cholangiocarcinoma.";
RL   J. Clin. Invest. 98:1313-1323(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Heart;
RX   PubMed=10974562; DOI=10.1016/S0378-1119(00)00299-7;
RA   Lim K.Y., Hong C.-S., Kim D.H.;
RT   "cDNA cloning and characterization of human cardiac junctin.";
RL   Gene 255:35-42(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=10956665; DOI=10.1074/jbc.M006753200;
RA   Dinchuk J.E., Henderson N.L., Burn T.C., Huber R., Ho S.P., Link J.,
RA   O'Neil K.T., Focht R.J., Scully M.S., Hollis J.M., Hollis G.F.,
RA   Friedman P.A.;
RT   "Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved
RT   isoform of Asph missing the catalytic domain share exons with
RT   junctin.";
RL   J. Biol. Chem. 275:39543-39554(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8), CALCIUM-BINDING, ALTERNATIVE
RP   SPLICING, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Muscle;
RX   PubMed=11007777; DOI=10.1074/jbc.M005473200;
RA   Treves S., Feriotto G., Moccagatta L., Gambari R., Zorzato F.;
RT   "Molecular cloning, expression, functional characterization,
RT   chromosomal localization, and gene structure of junctate, a novel
RT   integral calcium binding protein of sarco(endo)plasmic reticulum
RT   membrane.";
RL   J. Biol. Chem. 275:39555-39568(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Heart;
RX   PubMed=10767180; DOI=10.1006/mgme.2000.2966;
RA   Wetzel G.T., Ding S., Chen F.;
RT   "Molecular cloning of junctin from human and developing rabbit
RT   heart.";
RL   Mol. Genet. Metab. 69:252-258(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 9 AND 10).
RC   TISSUE=Hippocampus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5; 6 AND 7).
RC   TISSUE=Brain, and Pancreatic carcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   FUNCTION, CALCIUM-BINDING DOMAIN, INTERACTION WITH ORAI1 AND STIM1
RP   (ISOFORM 8), MUTAGENESIS OF 91-ASP--ASP-93, AND SUBCELLULAR LOCATION.
RX   PubMed=22586105; DOI=10.1073/pnas.1200667109;
RA   Srikanth S., Jew M., Kim K.D., Yee M.K., Abramson J., Gwack Y.;
RT   "Junctate is a Ca2+-sensing structural component of Orai1 and stromal
RT   interaction molecule 1 (STIM1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:8682-8687(2012).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-452 (ISOFORM 1), AND
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-64 (ISOFORM 3).
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   INTERACTION WITH CASQ2 (ISOFORM 4), AND SUBCELLULAR LOCATION.
RX   PubMed=15485681; DOI=10.1016/j.cardiores.2004.09.009;
RA   Houle T.D., Ram M.L., Cala S.E.;
RT   "Calsequestrin mutant D307H exhibits depressed binding to its protein
RT   targets and a depressed response to calcium.";
RL   Cardiovasc. Res. 64:227-233(2004).
RN   [16]
RP   FUNCTION (ISOFORM 1), AND CATALYTIC ACTIVITY.
RX   PubMed=11773073; DOI=10.1074/jbc.M110389200;
RA   Dinchuk J.E., Focht R.J., Kelley J.A., Henderson N.L.,
RA   Zolotarjova N.I., Wynn R., Neff N.T., Link J., Huber R.M., Burn T.C.,
RA   Rupar M.J., Cunningham M.R., Selling B.H., Ma J., Stern A.A.,
RA   Hollis G.F., Stein R.B., Friedman P.A.;
RT   "Absence of post-translational aspartyl beta-hydroxylation of
RT   epidermal growth factor domains in mice leads to developmental defects
RT   and an increased incidence of intestinal neoplasia.";
RL   J. Biol. Chem. 277:12970-12977(2002).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 562-758 IN COMPLEX WITH
RP   N-OXALYOLGLYCINE AND ZINC IONS, AND DISULFIDE BOND.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human aspartate beta-hydroxylase isoform A.";
RL   Submitted (MAY-2011) to the PDB data bank.
RN   [19]
RP   INVOLVEMENT IN FDLAB, AND VARIANT FDLAB TRP-735.
RX   PubMed=24768550; DOI=10.1016/j.ajhg.2014.04.002;
RA   Patel N., Khan A.O., Mansour A., Mohamed J.Y., Al-Assiri A.,
RA   Haddad R., Jia X., Xiong Y., Megarbane A., Traboulsi E.I.,
RA   Alkuraya F.S.;
RT   "Mutations in ASPH cause facial dysmorphism, lens dislocation,
RT   anterior-segment abnormalities, and spontaneous filtering blebs, or
RT   Traboulsi syndrome.";
RL   Am. J. Hum. Genet. 94:755-759(2014).
CC   -!- FUNCTION: Isoform 1: specifically hydroxylates an Asp or Asn
CC       residue in certain epidermal growth factor-like (EGF) domains of a
CC       number of proteins. {ECO:0000269|PubMed:11773073}.
CC   -!- FUNCTION: Isoform 8: membrane-bound Ca(2+)-sensing protein, which
CC       is a structural component of the ER-plasma membrane junctions.
CC       Isoform 8 regulates the activity of Ca(+2) released-activated
CC       Ca(+2) (CRAC) channels in T-cells. {ECO:0000269|PubMed:22586105}.
CC   -!- CATALYTIC ACTIVITY: Peptide L-aspartate + 2-oxoglutarate + O(2) =
CC       peptide 3-hydroxy-L-aspartate + succinate + CO(2).
CC       {ECO:0000269|PubMed:11773073}.
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000250|UniProtKB:Q28056};
CC   -!- SUBUNIT: Monomer (By similarity). Isoform 8 interacts with ORAI1
CC       and STIM1. Isoform 4 interacts with CASQ2.
CC       {ECO:0000250|UniProtKB:Q28056, ECO:0000269|PubMed:15485681,
CC       ECO:0000269|PubMed:22586105}.
CC   -!- INTERACTION:
CC       O43681:ASNA1; NbExp=3; IntAct=EBI-2967294, EBI-2515857;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane;
CC       Single-pass type II membrane protein
CC       {ECO:0000250|UniProtKB:Q28056}.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Sarcoplasmic reticulum membrane;
CC       Single-pass type II membrane protein
CC       {ECO:0000305|PubMed:15485681}.
CC   -!- SUBCELLULAR LOCATION: Isoform 8: Endoplasmic reticulum membrane;
CC       Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:22586105}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=10;
CC         Comment=Comment: 3 functionally distinct proteins are produced
CC         by alternative splicing: Aspartyl/asparaginyl beta-hydroxylase,
CC         Junctin and Junctate. Additional isoforms are produced by
CC         alternative splicing. {ECO:0000269|PubMed:11007777};
CC       Name=1;
CC         IsoId=Q12797-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12797-2; Sequence=VSP_039169, VSP_039170;
CC       Name=3; Synonyms=Junctin-1, Cardiac junctin;
CC         IsoId=Q12797-3; Sequence=VSP_039165, VSP_039166, VSP_039167,
CC                                  VSP_039168;
CC         Note=Glycosylated on Asn-64.;
CC       Name=4; Synonyms=Junctin-2, Junctin;
CC         IsoId=Q12797-4; Sequence=VSP_039165, VSP_039167, VSP_039168;
CC       Name=5;
CC         IsoId=Q12797-5; Sequence=VSP_039165, VSP_039166, VSP_044238,
CC                                  VSP_039169, VSP_039170;
CC       Name=10;
CC         IsoId=Q12797-10; Sequence=VSP_039165;
CC       Name=6;
CC         IsoId=Q12797-6; Sequence=VSP_044236, VSP_039169, VSP_039170;
CC       Name=7;
CC         IsoId=Q12797-7; Sequence=VSP_039166, VSP_044235, VSP_044237;
CC       Name=8; Synonyms=Junctate;
CC         IsoId=Q12797-8; Sequence=VSP_039165, VSP_039166, VSP_039169,
CC                                  VSP_039170;
CC       Name=9;
CC         IsoId=Q12797-9; Sequence=VSP_039165, VSP_039166, VSP_044236,
CC                                  VSP_039169, VSP_039170;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is detected in all tissues tested.
CC       Isoform 8 is mainly expressed in pancreas, heart, brain, kidney
CC       and liver. Isoform 8 is expressed in kidney (at protein level).
CC       {ECO:0000269|PubMed:11007777}.
CC   -!- DISEASE: Facial dysmorphism, lens dislocation, anterior segment
CC       abnormalities, and spontaneous filtering blebs (FDLAB)
CC       [MIM:601552]: A syndrome characterized by dislocated crystalline
CC       lenses and anterior segment abnormalities in association with a
CC       distinctive facies involving flat cheeks and a beaked nose. Some
CC       affected individuals develop highly unusual non-traumatic
CC       conjunctival cysts (filtering blebs).
CC       {ECO:0000269|PubMed:24768550}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the aspartyl/asparaginyl beta-hydroxylase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03109; AAA82108.1; -; mRNA.
DR   EMBL; S83325; AAB50779.1; -; mRNA.
DR   EMBL; AF224468; AAF82246.1; -; mRNA.
DR   EMBL; AF224469; AAF82247.1; -; mRNA.
DR   EMBL; AF289489; AAG40811.1; -; mRNA.
DR   EMBL; AF306765; AAG42257.1; -; mRNA.
DR   EMBL; AF184241; AAG16983.1; -; mRNA.
DR   EMBL; AK295528; BAG58441.1; -; mRNA.
DR   EMBL; AK304314; BAG65166.1; -; mRNA.
DR   EMBL; AC067881; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090094; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471068; EAW86841.1; -; Genomic_DNA.
DR   EMBL; CH471068; EAW86840.1; -; Genomic_DNA.
DR   EMBL; CH471068; EAW86847.1; -; Genomic_DNA.
DR   EMBL; CH471068; EAW86848.1; -; Genomic_DNA.
DR   EMBL; CH471068; EAW86849.1; -; Genomic_DNA.
DR   EMBL; BC025236; AAH25236.1; -; mRNA.
DR   EMBL; BC066929; AAH66929.1; -; mRNA.
DR   EMBL; BC142967; AAI42968.1; -; mRNA.
DR   EMBL; BC144362; AAI44363.1; -; mRNA.
DR   CCDS; CCDS34898.1; -. [Q12797-1]
DR   CCDS; CCDS34899.1; -. [Q12797-4]
DR   CCDS; CCDS34900.1; -. [Q12797-3]
DR   CCDS; CCDS43742.1; -. [Q12797-2]
DR   CCDS; CCDS47866.1; -. [Q12797-8]
DR   CCDS; CCDS55234.1; -. [Q12797-10]
DR   CCDS; CCDS55235.1; -. [Q12797-9]
DR   CCDS; CCDS55236.1; -. [Q12797-5]
DR   CCDS; CCDS55237.1; -. [Q12797-6]
DR   CCDS; CCDS55238.1; -. [Q12797-7]
DR   PIR; I38423; I38423.
DR   RefSeq; NP_001158222.1; NM_001164750.1. [Q12797-10]
DR   RefSeq; NP_001158223.1; NM_001164751.1. [Q12797-5]
DR   RefSeq; NP_001158225.1; NM_001164753.1. [Q12797-9]
DR   RefSeq; NP_001158227.1; NM_001164755.1. [Q12797-6]
DR   RefSeq; NP_001158228.1; NM_001164756.1. [Q12797-7]
DR   RefSeq; NP_004309.2; NM_004318.3. [Q12797-1]
DR   RefSeq; NP_064549.1; NM_020164.4. [Q12797-3]
DR   RefSeq; NP_115855.1; NM_032466.3. [Q12797-2]
DR   RefSeq; NP_115856.1; NM_032467.3. [Q12797-4]
DR   RefSeq; NP_115857.1; NM_032468.4. [Q12797-8]
DR   UniGene; Hs.332422; -.
DR   PDB; 5APA; X-ray; 2.05 A; A=562-758.
DR   PDBsum; 5APA; -.
DR   ProteinModelPortal; Q12797; -.
DR   SMR; Q12797; -.
DR   BioGrid; 106936; 40.
DR   IntAct; Q12797; 47.
DR   STRING; 9606.ENSP00000368767; -.
DR   DrugBank; DB00128; L-Aspartic Acid.
DR   DrugBank; DB00139; Succinic acid.
DR   TCDB; 8.A.28.1.5; the ankyrin (ankyrin) family.
DR   iPTMnet; Q12797; -.
DR   PhosphoSitePlus; Q12797; -.
DR   SwissPalm; Q12797; -.
DR   BioMuta; ASPH; -.
DR   DMDM; 145559444; -.
DR   EPD; Q12797; -.
DR   MaxQB; Q12797; -.
DR   PaxDb; Q12797; -.
DR   PeptideAtlas; Q12797; -.
DR   PRIDE; Q12797; -.
DR   TopDownProteomics; Q12797-1; -. [Q12797-1]
DR   TopDownProteomics; Q12797-2; -. [Q12797-2]
DR   DNASU; 444; -.
DR   Ensembl; ENST00000356457; ENSP00000348841; ENSG00000198363. [Q12797-2]
DR   Ensembl; ENST00000379449; ENSP00000368762; ENSG00000198363. [Q12797-7]
DR   Ensembl; ENST00000379454; ENSP00000368767; ENSG00000198363. [Q12797-1]
DR   Ensembl; ENST00000389204; ENSP00000373856; ENSG00000198363. [Q12797-3]
DR   Ensembl; ENST00000517847; ENSP00000429954; ENSG00000198363. [Q12797-8]
DR   Ensembl; ENST00000517903; ENSP00000430245; ENSG00000198363. [Q12797-5]
DR   Ensembl; ENST00000518068; ENSP00000429286; ENSG00000198363. [Q12797-6]
DR   Ensembl; ENST00000522603; ENSP00000436188; ENSG00000198363. [Q12797-4]
DR   Ensembl; ENST00000522835; ENSP00000429160; ENSG00000198363. [Q12797-9]
DR   GeneID; 444; -.
DR   KEGG; hsa:444; -.
DR   UCSC; uc003xuj.4; human. [Q12797-1]
DR   CTD; 444; -.
DR   DisGeNET; 444; -.
DR   GeneCards; ASPH; -.
DR   GeneCards; ENSG00000283485; -.
DR   HGNC; HGNC:757; ASPH.
DR   HPA; HPA055161; -.
DR   HPA; HPA059303; -.
DR   MalaCards; ASPH; -.
DR   MIM; 600582; gene.
DR   MIM; 601552; phenotype.
DR   neXtProt; NX_Q12797; -.
DR   OpenTargets; ENSG00000198363; -.
DR   PharmGKB; PA25056; -.
DR   eggNOG; KOG3696; Eukaryota.
DR   eggNOG; COG3555; LUCA.
DR   GeneTree; ENSGT00530000063281; -.
DR   HOGENOM; HOG000231622; -.
DR   HOVERGEN; HBG004290; -.
DR   InParanoid; Q12797; -.
DR   KO; K00476; -.
DR   OMA; RNENACK; -.
DR   OrthoDB; EOG091G0H5R; -.
DR   PhylomeDB; Q12797; -.
DR   TreeFam; TF312799; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   ChiTaRS; ASPH; human.
DR   EvolutionaryTrace; Q12797; -.
DR   GeneWiki; ASPH; -.
DR   GenomeRNAi; 444; -.
DR   PRO; PR:Q12797; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000198363; -.
DR   CleanEx; HS_ASPH; -.
DR   ExpressionAtlas; Q12797; baseline and differential.
DR   Genevisible; Q12797; HS.
DR   GO; GO:0034704; C:calcium channel complex; TAS:BHF-UCL.
DR   GO; GO:0032541; C:cortical endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0014701; C:junctional sarcoplasmic reticulum membrane; TAS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0033018; C:sarcoplasmic reticulum lumen; TAS:BHF-UCL.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; TAS:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; TAS:BHF-UCL.
DR   GO; GO:0004597; F:peptide-aspartate beta-dioxygenase activity; TAS:ProtInc.
DR   GO; GO:0008307; F:structural constituent of muscle; TAS:ProtInc.
DR   GO; GO:0005198; F:structural molecule activity; TAS:ProtInc.
DR   GO; GO:0097202; P:activation of cysteine-type endopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:0032237; P:activation of store-operated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0005513; P:detection of calcium ion; TAS:BHF-UCL.
DR   GO; GO:0060325; P:face morphogenesis; IEA:Ensembl.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0035108; P:limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0007389; P:pattern specification process; IEA:Ensembl.
DR   GO; GO:0042264; P:peptidyl-aspartic acid hydroxylation; IEA:Ensembl.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; IDA:UniProtKB.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; IDA:UniProtKB.
DR   GO; GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL.
DR   GO; GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; ISS:BHF-UCL.
DR   GO; GO:0010649; P:regulation of cell communication by electrical coupling; TAS:BHF-UCL.
DR   GO; GO:0031585; P:regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IDA:UniProtKB.
DR   GO; GO:1901879; P:regulation of protein depolymerization; IEA:Ensembl.
DR   GO; GO:0031647; P:regulation of protein stability; IEA:Ensembl.
DR   GO; GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; TAS:BHF-UCL.
DR   GO; GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL.
DR   GO; GO:0033198; P:response to ATP; IDA:UniProtKB.
DR   Gene3D; 2.60.120.330; -; 1.
DR   InterPro; IPR007943; Asp-B-hydro/Triadin_dom.
DR   InterPro; IPR007803; Asp/Arg/Pro-Hydrxlase.
DR   InterPro; IPR027443; IPNS-like.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom.
DR   InterPro; IPR019734; TPR_repeat.
DR   Pfam; PF05279; Asp-B-Hydro_N; 1.
DR   Pfam; PF05118; Asp_Arg_Hydrox; 1.
DR   SMART; SM00028; TPR; 2.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   PROSITE; PS50005; TPR; 2.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Complete proteome;
KW   Dioxygenase; Disease mutation; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Iron; Membrane; Metal-binding; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Sarcoplasmic reticulum; Signal-anchor; TPR repeat; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    758       Aspartyl/asparaginyl beta-hydroxylase.
FT                                /FTId=PRO_0000064706.
FT   TOPO_DOM      1     53       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     54     74       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     75    758       Lumenal. {ECO:0000255}.
FT   REPEAT      341    374       TPR 1.
FT   REPEAT      454    487       TPR 2.
FT   REPEAT      489    521       TPR 3.
FT   REPEAT      525    557       TPR 4.
FT   CA_BIND      90    102       {ECO:0000305|PubMed:22586105}.
FT   REGION      688    690       2-oxoglutarate binding.
FT                                {ECO:0000269|Ref.18}.
FT   COMPBIAS      9     29       Ser-rich.
FT   COMPBIAS    111    312       Glu-rich.
FT   COMPBIAS    323    332       Poly-Lys.
FT   METAL       679    679       Iron. {ECO:0000305}.
FT   METAL       725    725       Iron. {ECO:0000305}.
FT   BINDING     625    625       2-oxoglutarate. {ECO:0000269|Ref.18}.
FT   BINDING     668    668       2-oxoglutarate. {ECO:0000269|Ref.18}.
FT   BINDING     735    735       2-oxoglutarate. {ECO:0000269|Ref.18}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    452    452       N-linked (GlcNAc...) asparagine.
FT   CARBOHYD    706    706       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    641    648       {ECO:0000269|Ref.18}.
FT   VAR_SEQ       1     34       MAQRKNAKSSGNSSSSGSGSGSTSAGSSSPGARR -> MAE
FT                                DK (in isoform 3, isoform 4, isoform 5,
FT                                isoform 8, isoform 9 and isoform 10).
FT                                {ECO:0000303|PubMed:10767180,
FT                                ECO:0000303|PubMed:10974562,
FT                                ECO:0000303|PubMed:11007777,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039165.
FT   VAR_SEQ      84     84       L -> LAKAKDFRYNLSEVLQ (in isoform 3,
FT                                isoform 5, isoform 7, isoform 8 and
FT                                isoform 9). {ECO:0000303|PubMed:10767180,
FT                                ECO:0000303|PubMed:10974562,
FT                                ECO:0000303|PubMed:11007777,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039166.
FT   VAR_SEQ     108    239       GLKERSTSEPAVPPEEAEPHTEPEEQVPVEAEPQNIEDEAK
FT                                EQIQSLLHEMVHAEHVEGEDLQQEDGPTGEPQQEDDEFLMA
FT                                TDVDDRFETLEPEVSHEETEHSYHVEETVSQDCNQDMEEMM
FT                                SEQENPDSS -> EGPSGVAKRKTKAKVKELTKEELKKEKE
FT                                KPESRKESKNEERKKGKKEDVRKDKKIADADLSRKESPKGK
FT                                KDREKEKVDLEKSAKTKENRKKSTNMKDVSSKMASRDKDDR
FT                                KESRSSTRYAHLTKGNTQKRNG (in isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:10767180,
FT                                ECO:0000303|PubMed:10974562}.
FT                                /FTId=VSP_039167.
FT   VAR_SEQ     110    188       KERSTSEPAVPPEEAEPHTEPEEQVPVEAEPQNIEDEAKEQ
FT                                IQSLLHEMVHAEHVEGEDLQQEDGPTGEPQQEDDEFLM ->
FT                                TKDGSNENIDSLEEVLNILAEESSDWFYGFLSFLYDIMTPF
FT                                EMLEEEEEESETADGVDGTSQNEGVQGKTCVILDLHNQ
FT                                (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044235.
FT   VAR_SEQ     164    206       Missing (in isoform 6 and isoform 9).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044236.
FT   VAR_SEQ     189    758       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044237.
FT   VAR_SEQ     240    758       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:10767180,
FT                                ECO:0000303|PubMed:10974562}.
FT                                /FTId=VSP_039168.
FT   VAR_SEQ     264    264       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044238.
FT   VAR_SEQ     312    313       ET -> DT (in isoform 2, isoform 5,
FT                                isoform 6, isoform 8 and isoform 9).
FT                                {ECO:0000303|PubMed:10956665,
FT                                ECO:0000303|PubMed:11007777,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039169.
FT   VAR_SEQ     314    758       Missing (in isoform 2, isoform 5, isoform
FT                                6, isoform 8 and isoform 9).
FT                                {ECO:0000303|PubMed:10956665,
FT                                ECO:0000303|PubMed:11007777,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039170.
FT   VARIANT     354    354       R -> M (in dbSNP:rs6995412).
FT                                /FTId=VAR_053781.
FT   VARIANT     735    735       R -> W (in FDLAB; dbSNP:rs374385878).
FT                                {ECO:0000269|PubMed:24768550}.
FT                                /FTId=VAR_071821.
FT   MUTAGEN      91     93       DAD->AAA: Increase in cytoplasmic Ca(2+)
FT                                via activation of endogenous CRAC
FT                                channels. {ECO:0000269|PubMed:22586105}.
FT   CONFLICT    519    519       D -> N (in Ref. 7; BAG65166).
FT                                {ECO:0000305}.
FT   CONFLICT    565    565       Y -> I (in Ref. 1; AAA82108).
FT                                {ECO:0000305}.
FT   CONFLICT    575    577       WWT -> CG (in Ref. 1; AAA82108).
FT                                {ECO:0000305}.
FT   CONFLICT    585    585       E -> Q (in Ref. 1; AAA82108).
FT                                {ECO:0000305}.
FT   CONFLICT    599    599       D -> Y (in Ref. 7; BAG65166).
FT                                {ECO:0000305}.
FT   CONFLICT    709    709       K -> R (in Ref. 2; AAB50779).
FT                                {ECO:0000305}.
FT   CONFLICT    734    734       F -> L (in Ref. 7; BAG65166).
FT                                {ECO:0000305}.
FT   STRAND      574    576       {ECO:0000244|PDB:5APA}.
FT   HELIX       578    581       {ECO:0000244|PDB:5APA}.
FT   HELIX       584    592       {ECO:0000244|PDB:5APA}.
FT   HELIX       594    604       {ECO:0000244|PDB:5APA}.
FT   TURN        607    610       {ECO:0000244|PDB:5APA}.
FT   STRAND      620    623       {ECO:0000244|PDB:5APA}.
FT   STRAND      625    632       {ECO:0000244|PDB:5APA}.
FT   HELIX       638    643       {ECO:0000244|PDB:5APA}.
FT   HELIX       645    651       {ECO:0000244|PDB:5APA}.
FT   HELIX       655    658       {ECO:0000244|PDB:5APA}.
FT   STRAND      664    670       {ECO:0000244|PDB:5APA}.
FT   STRAND      674    679       {ECO:0000244|PDB:5APA}.
FT   STRAND      686    694       {ECO:0000244|PDB:5APA}.
FT   STRAND      697    704       {ECO:0000244|PDB:5APA}.
FT   STRAND      707    709       {ECO:0000244|PDB:5APA}.
FT   STRAND      716    719       {ECO:0000244|PDB:5APA}.
FT   STRAND      725    729       {ECO:0000244|PDB:5APA}.
FT   STRAND      731    733       {ECO:0000244|PDB:5APA}.
FT   STRAND      735    743       {ECO:0000244|PDB:5APA}.
FT   HELIX       749    754       {ECO:0000244|PDB:5APA}.
SQ   SEQUENCE   758 AA;  85863 MW;  4AE56D1D8DF0AF0C CRC64;
     MAQRKNAKSS GNSSSSGSGS GSTSAGSSSP GARRETKHGG HKNGRKGGLS GTSFFTWFMV
     IALLGVWTSV AVVWFDLVDY EEVLGKLGIY DADGDGDFDV DDAKVLLGLK ERSTSEPAVP
     PEEAEPHTEP EEQVPVEAEP QNIEDEAKEQ IQSLLHEMVH AEHVEGEDLQ QEDGPTGEPQ
     QEDDEFLMAT DVDDRFETLE PEVSHEETEH SYHVEETVSQ DCNQDMEEMM SEQENPDSSE
     PVVEDERLHH DTDDVTYQVY EEQAVYEPLE NEGIEITEVT APPEDNPVED SQVIVEEVSI
     FPVEEQQEVP PETNRKTDDP EQKAKVKKKK PKLLNKFDKT IKAELDAAEK LRKRGKIEEA
     VNAFKELVRK YPQSPRARYG KAQCEDDLAE KRRSNEVLRG AIETYQEVAS LPDVPADLLK
     LSLKRRSDRQ QFLGHMRGSL LTLQRLVQLF PNDTSLKNDL GVGYLLIGDN DNAKKVYEEV
     LSVTPNDGFA KVHYGFILKA QNKIAESIPY LKEGIESGDP GTDDGRFYFH LGDAMQRVGN
     KEAYKWYELG HKRGHFASVW QRSLYNVNGL KAQPWWTPKE TGYTELVKSL ERNWKLIRDE
     GLAVMDKAKG LFLPEDENLR EKGDWSQFTL WQQGRRNENA CKGAPKTCTL LEKFPETTGC
     RRGQIKYSIM HPGTHVWPHT GPTNCRLRMH LGLVIPKEGC KIRCANETKT WEEGKVLIFD
     DSFEHEVWQD ASSFRLIFIV DVWHPELTPQ QRRSLPAI
//
